Clinical Trial Update: The Durability of Early RA Disease Control After Tocilizumab Withdrawal: A Canadian Experience

View source ↗

Summary

This clinical trial update discusses the durability of disease control after stopping tocilizumab in patients with early rheumatoid arthritis in Canada, noting …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Actemra (tocilizumab) (tocilizumab)

Snippet

Sponsor: Pope Research Corporation | Conditions: Rheumatoid Arthritis | Status: WITHDRAWN